EVEREST GROUP ($EG) posted quarterly earnings results for Q4 2025 on Wednesday, February 4th. The company reported earnings of $13.26 per share, missing estimates of $13.56 by $0.30. The company also reported revenue of $4,424,000,000, beating estimates of $4,030,647,500 by $393,352,500.
Stock price change since market close: -1.07%
You can see Quiver Quantitative's $EG stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EVEREST GROUP Insider Trading Activity
EVEREST GROUP insiders have traded $EG stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EG stock by insiders over the last 6 months:
- WILLIAM F JR GALTNEY purchased 11,385 shares for an estimated $3,499,521
- ALLAN LEVINE purchased 3,100 shares for an estimated $948,848
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EVEREST GROUP Hedge Fund Activity
We have seen 313 institutional investors add shares of EVEREST GROUP stock to their portfolio, and 360 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC added 830,418 shares (+70.3%) to their portfolio in Q3 2025, for an estimated $290,837,296
- FIRST TRUST ADVISORS LP removed 273,003 shares (-44.4%) from their portfolio in Q3 2025, for an estimated $95,613,840
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 267,402 shares (+75.6%) to their portfolio in Q3 2025, for an estimated $93,652,202
- PITCAIRN CO removed 261,181 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $91,473,421
- WELLINGTON MANAGEMENT GROUP LLP removed 218,415 shares (-15.0%) from their portfolio in Q3 2025, for an estimated $76,495,485
- ALLIANCEBERNSTEIN L.P. added 178,536 shares (+157.5%) to their portfolio in Q3 2025, for an estimated $62,528,663
- CAUSEWAY CAPITAL MANAGEMENT LLC added 175,686 shares (+inf%) to their portfolio in Q3 2025, for an estimated $61,530,507
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EVEREST GROUP Congressional Stock Trading
Members of Congress have traded $EG stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EG stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
EVEREST GROUP Analyst Ratings
Wall Street analysts have issued reports on $EG in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/08/2026
- Keefe, Bruyette & Woods issued a "Outperform" rating on 01/06/2026
- Raymond James issued a "Outperform" rating on 09/22/2025
To track analyst ratings and price targets for EVEREST GROUP, check out Quiver Quantitative's $EG forecast page.
EVEREST GROUP Price Targets
Multiple analysts have issued price targets for $EG recently. We have seen 10 analysts offer price targets for $EG in the last 6 months, with a median target of $363.5.
Here are some recent targets:
- Ryan Tunis from Cantor Fitzgerald set a target price of $344.0 on 01/14/2026
- Elyse Greenspan from Wells Fargo set a target price of $332.0 on 01/13/2026
- Alex Scott from Barclays set a target price of $377.0 on 01/08/2026
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $430.0 on 01/06/2026
- Yaron Kinar from Mizuho set a target price of $359.0 on 12/16/2025
- Andrew Kligerman from TD Cowen set a target price of $365.0 on 12/15/2025
- David Motemaden from Evercore ISI Group set a target price of $384.0 on 10/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.